Congenital Cytomegalovirus - An Unrecognized and Preventable Problem: Fundamentals of Prevention, Diagnosis and Management

Presented at: Microbiology Week Virtual Event Series 2020

Sponsored by: Diasorin

Speaker

William Rawlinson, PhD

Director of Serology and Virology Division (SAViD), Director Organ and Tissue Donor screening laboratory, Director NSW State Reference Laboratory for HIV, Chair Biosecurity Quality Assurance
BIOGRAPHY

Abstract

Congenital CMV is the most frequent infectious cause of neonatal malformation in developed nations. It is more prevalent than other neonatal conditions such as spina bifida and Down syndrome. However, this disease has been under-recognized by many health authorities around the world, as well as largely unknown among pregnant women and their partners. Congenital CMV can lead to hearing loss, neurological impairment and even death, however appropriate and timely treatment can minimize the severity and reduce the burden of this disease. This presentation will address the fundamentals of congenital CMV in prevention, diagnosis and management. We will touch on some recent research, and how we can move forward to continue reducing the impact of congenital CMV globally.

Learning Objectives:

1. Describe the clinical presentation of congenital CMV

2. Understand diagnosis and indications for testing and possibilities of screening

3. Recognize the opportunities for prevention, management and therapeutic strategies

4. Understand research strategies in development to reduce the global impact of congenital CMV